Corpus ID: 2869040

Pharmacological Control of Receptor of Advanced Glycation End-Products and its Biological Effects in Psoriasis

@article{Mezentsev2013PharmacologicalCO,
  title={Pharmacological Control of Receptor of Advanced Glycation End-Products and its Biological Effects in Psoriasis},
  author={Alexandre Mezentsev and Sergey Bruskin and Anna G. Soboleva and Vladimir Sobolev and Eleonora Piruzian},
  journal={International Journal of Biomedical Science : IJBS},
  year={2013},
  volume={9},
  pages={112 - 122}
}
Receptor for advanced glycation end-products is implicated in a development of chronic inflammatory response. Aim of this paper is to provide a review on commercial and experimental medicines that can interfere with RAGE and signaling through RAGE. We searched three bibliographical databases (PubMed, Web of Science and MEDLINE) for the publications from 2005 to March 2012 and identified 5 major groups of agents that can interfere with RAGE biological effects. In the first part of this paper, we… Expand
Advanced Glycation End Products in the Pathogenesis of Psoriasis
TLDR
Intensified glycation of proteins in psoriasis skin might have a role in fueling cutaneous inflammation, and AGEs released from psoriatic skin may increase metabolic and cardiovascular risk in patients with severe disease. Expand
Advanced Glycation End Products are Increased in the Skin and Blood of Patients with Severe Psoriasis.
TLDR
Patients with severe psoriasis have accumulation of skin and serum AGEs, independent of associated metabolic disorders. Expand
Quantitative imaging of the receptor for advanced glycation end-products in prostate cancer
TLDR
This study has shown that RAGE-targeted cancer imaging is feasible and could significantly impact PCa management. Expand
Glycation and Skin Aging
Our skin, just like our whole body is submitted to aging. Important changes occur: skin gets dryer, thinner, age spots appear. It becomes less elastic and more rigid, fine lines and wrinkles appear,Expand
Tannic acid modulates NFκB signaling pathway and skin inflammation in NC/Nga mice through PPARγ expression.
TLDR
Results demonstrate that, DfE induced skin inflammation might be mediated through NFκB signaling and tannic acid may be a potential therapeutic agent for AD, which may possibly act via induction of PPARγ protein. Expand
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end products.
TLDR
The results of this cross-sectional controlled study might suggest a possible physio-pathological role of AGEs in the transepidermal elimination mechanisms involved in certain APDs. Expand
Genetically predetermined limitation in HaCaT cells that affects their ability to serve as an experimental model of psoriasis
TLDR
It is concluded that HaCaT cells have a sufficient limitation as a cellular model of psoriasis due to their treatment with proinflammatory cytokines, namely TNF, IFNG, and IL17 does not increase their proliferation rate. Expand
Models in the Research Process of Psoriasis
TLDR
There is no one model that can meet all of the research needs of psoriasis and the choice model system will depend on the questions being addressed, so far. Expand
Characterisation of structural changes in collagen with Raman spectroscopy
Abstract Raman spectroscopy can detect conformational changes in collagen structures and these findings are reviewed in this article. More specifically, some progressive diseases are mainly caused byExpand
Three-Dimensional Skin Models of Psoriasis
TLDR
Three-dimensional models of psoriatic lesional skin occupy an intermediate position between cell cultures and animal-based models and can be used for drug screening and testing new pharmacological approaches. Expand
...
1
2
...

References

SHOWING 1-10 OF 151 REFERENCES
Novel inhibitors of advanced glycation endproducts (part II).
TLDR
Nearly half of the 29 novel inhibitors reported here are benzoic acid derivatives and related molecules, and found to be potent inhibitors of multistage glycation, AGE formation, and AGE-protein crosslinking. Expand
Novel inhibitors of advanced glycation endproducts.
TLDR
A new class of compounds are developed as potent inhibitors of glycation and AGE formation, including aryl (and heterocyclic) ureido, and ary l carboxamido phenoxy isobutyric acids and related molecules, which were found by in vitro assay methods to be potent inhibitors. Expand
Chelating Activity of Advanced Glycation End-product Inhibitors*
TLDR
Inhibition of AGE formation results primarily from the chelating or antioxidant activity of the AGE inhibitors, rather than their carbonyl trapping activity. Expand
The receptor RAGE: Bridging inflammation and cancer
TLDR
Molecular mechanisms through which RAGE signalling contributes to the establishment of a pro-tumourigenic microenvironment are summarized and recent findings that provide genetic evidence for an important role of RAGE in bridging inflammation and cancer are reviewed. Expand
Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response.
TLDR
It is proposed that the sites and time course of ligand-RAGE stimulation determine the phenotype produced by this axis, and that drawing the fine line between antagonism versus stimulation of the receptor in health and disease will depend on the full characterization of RAGE in repair versus injury. Expand
Combination of Medicinal Herbs KIOM-79 Reduces Advanced Glycation End Product Accumulation and the Expression of Inflammatory Factors in the Aorta of Zucker Diabetic Fatty Rats
TLDR
It is found that KIOM-79 attenuated the expression of inflammatory factors including NF-κB, MCP-1, VEGF, VCAM- 1, and iNOS in the aortas of ZDF rats and may prevent or retard the development of inflammation in diabetic vascular disease. Expand
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
TLDR
It is postulated that ACE inhibition reduces the accumulation of AGE in diabetes partly by increasing the production and secretion of sRAGE into plasma. Expand
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
TLDR
Despite broad experimental evidence for the role of RAGES in chronic disease, knowledge of its physiological function is still missing, limiting predictions about safety of long-term inhibition of RAGE’s ligand interaction in chronic diseases. Expand
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane‐bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
  • A. Raucci, Simona Cugusi, +6 authors M. Bianchi
  • Chemistry, Medicine
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2008
TLDR
It is shown here that most soluble RAGE, either produced by cell lines or present in human blood, is not recognized by an anti‐esRAGE antibody, and the data do not disprove the interpretation that high levels of soluble forms of RAGE protect against chronic inflammation, but suggest that they correlate with high Levels of ongoing inflammation. Expand
Role of receptor for advanced glycation end‐product (RAGE) and the JAK/STAT‐signaling pathway in AGE‐induced collagen production in NRK‐49F cells
TLDR
It was concluded that RAGE and the JAK2‐STAT1/STAT3 pathway were involved in AGE‐induced collagen production in NRK‐49F cells. Expand
...
1
2
3
4
5
...